Galactose-PEG dual conjugation of beta-(1-->3)-D-glucan schizophyllan for antisense oligonucleotides delivery to enhance the cellular uptake

Biomaterials. 2006 Mar;27(8):1626-35. doi: 10.1016/j.biomaterials.2005.08.023. Epub 2005 Sep 19.

Abstract

Antisense oligonucleotides (AS ODNs) are applied to silence a particular gene, and this approach is one of the potential gene therapies. However, naked oligonucleotides are easy to be degraded or absorbed in biological condition. Therefore, we need a carrier to deliver AS ODNs. This paper presents galactose moieties that were conjugated to the side chain of SPG to enhance cellular ingestion through endocytosis mediated by asialoglycoprotein receptor specifically located on parenchymal liver cells. We introduced galactose with two types of chemical bonds; amide and amine, and the amine connection showed lower ingestion and more toxicity than the amide one. Since PEG was known to induce endocytosis escape, we combined PEG and galactose aiming to provide both cellular up-take and subsequent endocytosis escape. We designed lactose or galactose moieties to attach to the end of the PEG chain that connects to the SPG side chain. When the PEG had the molecular weight of 5000-6000, the antisense effect reached the maximum. We believe that this new type of galactose and PEG dual conjugation broaden the horizon in antisense delivery.

MeSH terms

  • Biocompatible Materials*
  • Cell Line
  • Cell Line, Tumor
  • Drug Delivery Systems*
  • Galactose*
  • Humans
  • Oligonucleotides, Antisense / metabolism*
  • Polyethylene Glycols*
  • Sizofiran* / chemical synthesis
  • Sizofiran* / metabolism
  • Sizofiran* / pharmacology
  • beta-Glucans / chemical synthesis
  • beta-Glucans / metabolism
  • beta-Glucans / pharmacology*

Substances

  • Biocompatible Materials
  • Oligonucleotides, Antisense
  • beta-Glucans
  • Polyethylene Glycols
  • Sizofiran
  • beta-1,3-glucan
  • Galactose